Sucampo's glaucoma drug Rescula wins FDA clearance

12/13/2012 | American City Business Journals

The FDA approved the use of Sucampo Pharmaceuticals' Rescula, or unoprostone isopropyl, for intraocular pressure reduction in patients with ocular hypertension or open-angle glaucoma. Sucampo plans to launch the drug in the first quarter.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI